baber/WOPTO huggingface dataset:
Patent AU-2017337127-A1 (AU)
Title: Secure element installation and provisioning
Inventor: CHEN YUEXI
IPC: G06F12/14
Filed: 2017-10-02
Abstract: A device binding system includes generating and storing at the device a unique identifier based on device characteristics and a cryptographic function. The unique identifier is then registered with an authority. The self-generation of the unique identifier allows binding with an authority to occur after the device leaves a secure manufacturing environment or even after the device is in the hands of an end-user consumer. Once the binding occurs, the device can be part of trusted transactions for location tracking, fitness tracking, financial transactions or other interactions where identity and privacy are factors.
Patent AU-2017356848-A1 (AU)
Title: Technological emergence scoring and analysis platform
Inventor: GARNER JON G
IPC: G06N7/00
Filed: 2017-11-03
Abstract: Disclosed herein is a Technological Emergence Scoring and Analysis Platform. The platform provides emergence scores for terms and a set of emergence indicators based on the scores. The platform can be used to quantitatively distinguish scientific and technological emergent topics within a target data category. The platform can take a set of data comprising a plurality of records and calculate an emergence score for terms and phrases representing the terms' or phrases' technological emergence.
Patent AU-2017369525-A1 (AU)
Title: Connecting device and method for connecting a wall element in an elevator car
Inventor: STEINER ADRIAN
IPC: E04F13/08
Filed: 2017-11-29
Abstract: The present invention relates to an elevator car having a connecting device (1) and a wall element (10), and to a method for carrying out the connection. The elevator car according to the invention comprises a connecting device (1) for connecting at least one wall element with a raw ceiling of an elevator car (100). The connecting device (1) comprises at least one rail element (2) with two legs (3, 4), of which a first leg (3) bears in the mounted state against the raw ceiling and a second leg (4) comprises at least one mounting surface (5) for at least one wall element (10). The mounting surface (5) has at least one first recess (6) for suspending the wall element (10). The wall element (10) comprises at least one suspension element (13) at an edge (19) which faces upwardly in the mounted state for engaging into the first recess (6) of the connecting device (1).
Patent AU-2017370742-A1 (AU)
Title: Robotic cleaning device with operating speed variation based on environment
Inventor: GAGNE AURLE
IPC: G05D1/02
Filed: 2017-12-08
Abstract: A system and method of causing a robotic device to navigate an area, including accessing a map of an area of travel, causing a transport assembly of the robotic device to move the robotic device in the area at a first speed, collecting information about the area as the robotic device moves in the area by at least one sensor, and processing the information collected. The system and method also include comparing the information collected with the information regarding the area from the map, and determining a degree of confidence that the information collected matches the information regarding the area of travel from the map. When the determined degree of confidence is at or below a first threshold degree of confidence, a first reduced speed mode of operation causes the transport assembly of the robotic device to move at a second, lower speed.
Patent AU-2017376711-A1 (AU)
Title: Polymyxin derivative, preparation method and application thereof
Inventor: CUI ALONG
IPC: A61P31/04
Filed: 2017-12-15
Abstract: Provided are a polymyxin derivative having a general formula I structure, and a preparation method and an application thereof. The method for preparing the polymyxin derivative comprises the following steps: (1) an Fmoc-AA-OP side chain free amino group of a protected basic amino acid reacting with a halogenated resin to obtain an Fmoc-AA-OP-resin; (2) the Fmoc-AA-OP-resin being coupled one by one to obtain a linear peptide-resin; (3) the linear peptide-resin selectively removing a protective group, and carrying out solid-phase cyclization to obtain a cyclic peptide-resin; (4) the cyclic peptide-resin undergoing acidic hydrolysis and ether precipitation to obtain a crude product of a cyclic polypeptide; (5) the crude product being purified and/or salt transferred and lyophilized to obtain a pure product of the cyclic polypeptide. The polymyxin derivative may be used for preparing an antibacterial drug, and used in particular for preparing an antibacterial drug having an expanded antibacterial spectrum, improved antibacterial activity and reduced renal toxicity, comprising preparing an antibacterial drug against a "super bacteria" which carries the NDM-1 gene.
Patent AU-2017385661-A1 (AU)
Title: Composition for prevention and treatment of muscular diseases or for improvement of muscle function containing 3,5-dicaffeoylquinic acid or chrysanthemum extract
Inventor: HWANG JAE KWAN
IPC: A61K36/287
Filed: 2017-11-30
Abstract: The present invention relates to a composition for preventing or treating muscular diseases, which contains an extract of chrysanthemum and 3,5-dicaffeoylquinic acid as active ingredients. Specifically, since the present invention reduces mRNA expression of atrogin-1 and MuRF-1, which are major biomarkers involved in muscle protein degradation in muscle cells, and reduces muscle loss by increasing mRNA expression of mTOR protein, which is a major biomarker involved in muscle protein formation, and myogenin and MyoD, which are biomarkers associated with muscle differentiation, the present invention can be used for preventing and treating muscular diseases or improving muscle function. In addition, the chrysanthemum extract or the 3,5-dicaffeoylquinic acid has an effect of excellently improving exercise performance by increasing the activity of SIRT1 and PCG-1α which are major biomarkers involved in exercise performance. Moreover, since the present invention is a natural product, the present invention can be safely used without side effects and can be used as medicine, food, or cosmetics.
Patent AU-2017386515-A1 (AU)
Title: Method and system employing distinguishable polymerases for detecting ternary complexes and identifying cognate nucleotides
Inventor: CAYER DEVON
IPC: C12Q1/6827
Filed: 2017-12-21
Abstract: Method of identifying a cognate nucleotide (i.e., the "next correct nucleotide") for a primed template nucleic acid molecule. In some embodiments, an ordered or random array of primed target nucleic acids characterized by different cognate nucleotides can be evaluated using a single imaging step to identify different cognate nucleotides for a collection of different primed template nucleic acid molecules. An optional incorporation step can follow the identifying step. A polymerase different from the ones used in the binding and examination steps can be used to incorporate a nucleotide, such as a reversible terminator nucleotide, preliminary to identification of the next cognate nucleotide.
Patent WO-2019095011-A1 (WO)
Title: Test de cathinone
Inventor: FU SHANLIN
IPC: G01N33/48
Filed: 2018-11-15
Abstract: L'invention concerne une méthode de détection de la présence d'une fraction de cathinone dans un échantillon, tel qu'un échantillon de drogue illicite supposé, qui consiste à mettre l'échantillon en contact avec une solution comprenant de la néocuproïne, une source de cuivre (II) et un catalyseur et à observer un changement de couleur, qui lorsqu'il survient est en corrélation avec la présence de cathinone. La méthode peut fonctionner à température ambiante. Des éléments mécaniques peuvent être utilisés pour accélérer le changement de couleur si nécessaire.
Patent AU-2018202146-A1 (AU)
Title: A method for manufacturing a biocompatible cathode slurry for use in biocompatible batteries for a contact lens
Inventor: FLITSCH FREDERICK A
IPC: H01M10/04
Filed: 2018-03-26
Abstract: OF THE INVENTION Methods and apparatus to form biocompatible energization elements are described. In some examples, the methods and apparatus to form the biocompatible energization elements involve forming cavities comprising active cathode chemistry. The active elements of the cathode and anode are sealed with a biocompatible material. In some examples, a field of use for the methods and apparatus may include any biocompatible device or product that requires energization elements. FG1l25
Patent AU-2018202421-A1 (AU)
Title: Sporting or amusement apparatus
Inventor: HEASLY CLARE
IPC: A63B63/08
Filed: 2018-04-05
Abstract: SPORTING OR AMUSEMENT APPARATUS According to the present invention, there is provided a goal assembly including: a frame (11) defining the border or mouth of the goal; a controller (13); at least one scoring sensor (17) for detecting passage of a ball past the frame and into the goal, the sensor then providing a signal to the controller (13); and a visual display system Including one or more light source (14 or 14'); the visual display system being activated by the controller (13) so as to provide a visual display. Preferably, the visual display incorporates a changing or non-static light pattern on part or all of the frame (11) or a post (12) or surface on which the frame is disposed, As well as the visual display system, the goal assembly may incorporate an audio transmitter (20) which is activated by the controller (13) so as to provide an audio transmission. The frame (11) may, for example. be a hoop such as the ring of a netball goal or the hoop section of the basket of a basketball goal or the frame forming the mouth of a soccer goal.
Patent AU-2018202802-A1 (AU)
Title: Combinations of modalities for the treatment of diabetes
Inventor: ORBAN TIHAMER
IPC: A61K38/19
Filed: 2018-04-23
Abstract: H:amt\Interwoven\NRPortbl\DCC\AMT\16848273_l.docx-23/04/2018 A method of treating, preventing, or delaying the progression of Type 1 diabetes mellitus by administering an effective amount of a fusion protein composition comprising a T-cell co-stimulation antagonist and a portion of an immunoglobulin molecule and an effective amount of a Type 1 diabetes autoantigen. The method includes, for example, administering a cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) molecule and a Type 1 diabetes autoantigen. Pharmaceutical compositions are also provided herewith.
Patent AU-2018203189-A1 (AU)
Title: Methods of detecting neurological or neuropsychiatric diseases or conditions
Inventor: KASSIS AMIN I
IPC: C12Q1/68
Filed: 2018-05-08
Abstract: ll:\TRN\Interwoven\NRPortbl\DCC\TRN\10025881- .docx-2I 042016 This invention provides methods of using phagocytic cells alone or in combination with non-phagocytic cells in the diagnosis, prognosis, or monitoring of neurological or neuropsychiatric diseases or conditions. The invention also provides methods of using phagocytic cells alone or in combination with non-phagocytic cells to identify markers of neurological or neuropsychiatric diseases or conditions. Provided are methods of using phagocytic cells alone or in combination with non-phagocytic cells in the diagnosis, prognosis, or monitoring of neurological or neuropsychiatric diseases or conditions. Also provided are methods of using phagocytic cells alone or in combination with nonphagocytic cells to identify markers of neurological or neuropsychiatric diseases or conditions.
Patent AU-2018203753-A1 (AU)
Title: Monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
Inventor: WANG ZHUOZHI
IPC: C12P21/08
Filed: 2018-05-29
Abstract: C:\Interwoven\NRPortbl\DCC\FMT\17068486 _.docx-29/052018 Monoclonal antibodies against tissue factor pathway inhibitor (TFPI) Abstract Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided.
Patent AU-2018203832-A1 (AU)
Title: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
Inventor: DE VISSER PETER CHRISTIAN
IPC: A61P21/00
Filed: 2018-05-31
Abstract: Abstract The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing and/or delaying DMD or BMD. 10326474_1 (GHMatters) P97657.AU.1
Patent AU-2018204405-A1 (AU)
Title: Using a digital video effect to generate a video stream
Inventor: HUNDEMER HANK J
IPC: H04N21/24
Filed: 2018-06-19
Abstract: USING A DIGITAL VIDEO EFFECT TO GENERATE A VIDEO STREAM A method for use in connection with a television-broadcast system (100) comprising a news production system (104) and a master control system (108), the method comprising: making a determination that a stunt switcher (304) of the master control system (108) is scheduled to run a first DVE to modify a first video stream; responsive to making the determination that the stunt switcher (304) is scheduled to modify the first video stream, selecting a second DVE to run on a production switcher of the news production system by using mapping data that maps the first DVE to the second DVE; and causing the production switcher to run the selected second DVE, wherein running the selected second DVE causes the production switcher to generate the first video stream by modifying an input video stream.
Patent AU-2018206756-A1 (AU)
Title: Underwater system and method
Inventor: FARBER AMIT
IPC: B63G7/02
Filed: 2018-07-18
Abstract: Systems and methods are provided for underwater use. In one example the system includes an autonomous mother unmanned underwater vehicle (AMUV) and one or more auxiliary unmanned underwater vehicles (UUV). The AMUV is 5 configured for autonomously searching for and detecting undersea objects potentially present in an undersea region of interest (ROI), for generating object information relating to the objects detected thereby to enable identification of at least one object of interest (001) among the detected objects, and for selectively transporting the UUV to at least within a predetermined distance from a location of the 001. The 10 UUV is configured for interacting with the 001 at least within the predetermined distance. Such a system is further configured for providing verification information indicative of the interaction between the UUV and the 001. The AMUV includes a communications system at least configured for transmitting at one or both of the verification information and the object information. m 0 c?) c>J) 0 cv CD C) 0- C) Cfo 0 )v (00 Na o
Patent AU-2018208822-A1 (AU)
Title: Perforating gun for oil and gas wells
Inventor: DALY KERRY G
IPC: E21B43/1185
Filed: 2018-01-18
Abstract: A perforating gun, perforating gun system, and method for producing the same is provided. The perforating gun includes a body and at least one cavity liner. The body has an axial length extending between a first axial end and a second axial end, and an outer radial surface extending between the first and second axial ends, an inner bore, and at least one shaped charge cavity disposed in the outer radial surface. The at least one shaped charge cavity is in fluid communication with the inner bore. The at least one cavity liner is disposed in the shaped charge cavity and is configured to retain an explosive material within the shaped charge cavity.
Patent AU-2018216532-A1 (AU)
Title: Novel lactic acid bacteria and use thereof
Inventor: KIM DONG-HYUN
IPC: A61K35/747
Filed: 2018-01-31
Abstract: A particular Bifidobacterium spp. strain or particular Lactobacillus spp. strain according to the present invention is isolated from excrement of a human or cabbage kimchi, and thus is highly safe and has physiological activities such as an immunity regulatory effect and an inflammation reaction inhibiting effect. Therefore, the particular Bifidobacterium spp. strain or particular Lactobacillus spp. strain according to the present invention can be used as a material for regulating immunity and inhibiting inflammation reactions, and can also be used as a functional food and drug material useful for preventing, alleviating, or treating rhinitis, atopy, and asthma which are allergic diseases.
Patent AU-2018232944-A1 (AU)
Title: Combustion device
Inventor: MASUMOTO KENTARO
IPC: F23N3/00
Filed: 2018-09-19
Abstract: The combustion device includes: a burner 8; an igniter 8a; a fuel supply unit that supplies fuel to the burner 8; a blower fan 9 that supplies air for combustion; 5 an exhaust port 3 that discharges combustion exhaust; a device control unit 16 that, before ignition of fuel supplied to the burner 8 by operation of the igniter 8a, performs air purge of the burner 8 at a predetermined air blowing amount by driving the blower fan 9; and a setting means 16a that is set when a check valve 12 for preventing back flow of exhaust is connected to the exhaust port 3. When the to setting means 16a is set to indicate that the check valve 12 is connected, the device control unit 16 controls the operation of the blower fan 9 so that slow-start air purge is performed in which the time interval from the start of air purge until the predetermined air blowing amount is reached becomes longer, than in the case in which no such check valve is connected. [5 0 _ t~ t t~ t F -a 1=_ -7 t
Patent AU-2018237895-A1 (AU)
Title: Methods and nodes for determining a transmission data block size
Inventor: CHENG JUNG-FU
IPC: H04W72/04
Filed: 2018-03-20
Abstract: A method in a User Equipment (UE) for determining a transmission data block size is provided. The method comprises: obtaining parameters for a data transmission, the parameters including at least a number of layers, a number of allocated resource blocks, a modulation order and a code rate; determining an effective number of resource elements; determining a transmission data block size based on the obtained parameters and the determined effective number of resource elements; and performing one of transmitting and receiving data based on the determined transmission data block size.
Patent AU-2018244062-A1 (AU)
Title: Antibacterial biomedical implants and associated materials, apparatus, and methods
Inventor: MCENTIRE BRYAN J
IPC: C04B35/599
Filed: 2018-01-23
Abstract: Methods for improving the antibacterial characteristics of biomedical implants and related implants manufactured according to such methods. In some implementations, a biomedical implant comprising a silicon nitride ceramic material may be subjected to a surface roughening treatment so as to increase a surface roughness of at least a portion of the biomedical implant to a roughness profile having an arithmetic average of at least about 500 nm Ra. In some implementations, a coating may be applied to a biomedical implant. Such a coating may comprise a silicon nitride ceramic material, and may be applied instead of, or in addition to, the surface roughening treatment process.
Patent AU-2018249559-A1 (AU)
Title: Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
Inventor: BABICH JOHN W
IPC: C07K16/18
Filed: 2018-04-05
Abstract: The present technology provides compounds, as well as compositions including such compounds, useful for imaging and/or treatment of a glioma, a breast cancer, an adrenal cortical cancer, a cervical carcinoma, a vulvar carcinoma, an endometrial carcinoma, a primary ovarian carcinoma, a metastatic ovarian carcinoma, a non-small cell lung cancer, a small cell lung cancer, a bladder cancer, a colon cancer, a primary, gastric adenocarcinoma, a primary colorectal adenocarcinoma, a renal cell carcinoma, and/or a prostate cancer. The compounds are represented by the following formula: (I) or a pharmaceutically acceptable salt thereof.
Patent AU-2018276075-A1 (AU)
Title: A suspended ceiling hanger clip
Inventor: GLOFTIS JASON MICHAEL
IPC: E04B9/06
Filed: 2018-06-03
Abstract: The present invention relates to a suspended ceiling hanger clip and a suspended ceiling formed using the hanger clip. The suspended ceiling hanger clip has a longitudinally extending base having a first end and a second end and a pair of generally parallel co-extensive flanges extending downwardly from the base. At least one projection in each flange is formed with a ramp surface. An aperture is formed in the base for receiving an upper end of the elongate suspension rod therein. The suspension rod has a longitudinal axis extending along a length between spaced apart upper and lower ends, with the lower end having an attachment means. The upper end of the suspension rod extends through and is fixedly retained from removal from the aperture in the base of the hanger clip.
Patent AU-2018285453-A1 (AU)
Title: Compositions comprising a bacterial strain of the genus Megasphaera and uses thereof
Inventor: MULDER Imke Elisabeth
IPC: A61P25/00
Filed: 2018-06-14
Abstract: The invention provides compositions comprising bacterial strains for treating and preventing neurodegenerative disorders.
Patent AU-2018302097-A1 (AU)
Title: Compositions and methods for targeting CD33-expressing cancers
Inventor: DAVILA MARCO L
IPC: C07K16/00
Filed: 2018-07-17
Abstract: Disclosed are compositions and methods for targeted treatment of CD33-expressing cancers. In particular, chimeric antigen receptor (CAR) polypeptides are disclosed that can be used with adoptive cell transfer to target and kill CD33-expressing cancers. Also disclosed are immune effector cells, such as T cells or Natural Killer (NK) cells, that are engineered to express these CARs. Therefore, also disclosed are methods of providing an anti-tumor immunity in a subject with a CD33-expressing cancer that involves adoptive transfer of the disclosed immune effector cells engineered to express the disclosed CARs. Also disclosed are multivalent antibodies are disclosed that are able to engage T-cells to destroy CD33-expressing malignant cells.
Patent AU-2018314147-A1 (AU)
Title: Unitary actuator valve for downhole operations
Inventor: KAO CONRAD
IPC: E21B34/06
Filed: 2018-07-09
Abstract: A member includes a unitary body defining a first portion integrally joined with a second portion through one or more shear tabs. The first portion defines a piston portion having a first end section including an activation member, a second end section, and an intermediate portion extending therebetween. The second portion defines a piston ring member disposed adjacent the first end section and includes a first section having a first diameter and a second section having a second diameter that is greater than the first diameter.
Patent AU-2018317875-A1 (AU)
Title: Methods of determining donor cell-free DNA without donor genotype
Inventor: MITCHELL AOY TOMITA
IPC: C12Q1/68
Filed: 2018-08-17
Abstract: This invention relates to methods and systems for assessing an amount of non-subject nucleic acids, such as donor-specific cell-free DNA, in a sample from a subject. The methods and systems can include the simulation of non-subject genotype when unknown. The methods and systems provided herein can be used to determine risk of a condition, such as transplant rejection.